Jennifer Gill, M.D., Ph.D. Titles and Appointments Assistant Professor Schools Medical School | Graduate School Departments Dermatology Graduate Programs Cancer Biology You have reached the Academic Profile. For more information on the doctor and patient care, please visit the clinical profile. Biography Dr. Gill received her M.D. and Ph.D. (Immunology) degrees from the Medical Scientist Training Program at Washington University Medical School in St. Louis. Prior to joining the faculty, she completed her dermatology residency and a cancer biology postdoctoral fellowship at the University of Texas Southwestern Medical Center. She is board-certified by the American Board of Dermatology and sees patients with melanoma and advanced skin cancer in her dermatology clinic at UTSW Professional Office Building 2. In addition to clinical work, Dr. Gill runs a research laboratory focused on understanding the molecular and metabolic regulators of melanoma. Her specific interests include 1) Characterizing the role of the enzyme GAPDHS in melanoma progression and metastasis; 2) Determining how tumor metabolism impacts melanoma behavior, therapeutic response, and patient outcomes; and 3) Leveraging clinical and translational studies in patients to teach us about melanoma biology. Education Fellowship UT Southwestern Medical Center 2015, Dermatology Medical Education Washington University School of Medicine (2012) Other Washington University School of Medicine (2012), Doctor of Philosophy Graduate School Washington University School of Medicine in St. Louis (2012), Doctor of Philosophy Other Washington University School of Medicine in St. Louis (2012), Doctor of Philosophy Internship Texas Health Presbyterian Hospital Dallas (2013), Internal Medicine Residency UT Southwestern Medical Center (2016), Dermatology Research Interest Cancer metastasis Melanoma metastasis Targeted therapies for treatment of cancer Publications Clinical practice guidelines for the management of basal cell carcinoma in Gorlin syndrome Cahn BA, Zhang R, Sidwell AM, Adam CM, Tiv J, Murrar R, Koh J, Griffin T, Nadir U, Yi MD, Ahmed A, Ma M, Koza E, Haq M, Shi V, Bale AE, Lewin JM, Christensen SR, Waldman A, Harmon CB, Alt-Holland A, Arkin LM, Morrison JC, Bogart K, Gregory MD, Lohman ME, Rossi A, Marghoob AA, Goldberg L, Jiang SB, Giordano CN, Choi JN, Teng JM, Mittal BB, Vidimos AT, Leffell DJ, Xu YG, Haber R, Storrs PA, Tsoukas M, Samie FH, Bickers DR, Nehal KS, Mosterd K, Billingsley EM, Epstein EH, Elston D, Hodge T, Breneiser J, Spiegel BA, Bissell S, Stephenson AG, Daum NS, Roth KB, Michalowski M, Shelley C, McGoldrick P, Nadin C, Weiss M, Rubenstein R, Kibbi N, Worley B, Chang AL, Harms KL, Pearlman R, Hirner J, Kim J, Schwartz RA, Bailey RK, Freites-Martinez A, Mirza AN, Castner N, Levenson JL, Whitson R, Golda N, Akin RS, Lawrence N, Demer A, Scott JF, Beveridge MG, Deng L, Sauder MB, Baumann BC, Bermudez R, Gill JG, Lambert WC, Cognetta AB, Krakowski AC, Blalock TW, Wasserman DI, Harper C, Dunbar-Jacob J, Patel AB, Chu EY, Sarin KY, Tang JY, Ruiz ES, Duffy K, Merritt B, Grushchak S, Behshad R, Lear W, Bartus CL, Kheterpal M, Somani AK, Eickstaedt J, Jung J, Smith E, Gold N, Walsh M, Subbiah V, Benedetto AV, Bar A, Bordeaux JS, Huang CC, Cohen JV, Yu SS, Yusuf MB, Lukens JN, Cartee TV, Fosko SW, Neel VA, Council ML, Shahwan KT, Srivastava D, Lauterbach M, Solomon JA, Brown MR, Beek MV, Hanke CW, Lee P, Maher IA, Brown TS, Konda S, Khushalani NI, Eisen DB, Carr DR, Saleeby E, Maloney M, Brown M, Cohen PR, Gilchrest BA, Miller CJ, Rohrer TE, Carucci JA, Swift J, Oro AE, Babakoohi S, Hawryluk EB, Grant-Kels JM, Desciak EB, Landers JT, Alam M Journal of the American Academy of Dermatology 2026 Feb 94 485-494 Language barriers are associated with advanced presentation of melanoma in Hispanic patients: A retrospective case series Brown AB, Wix SN, Yip CH, Mafong K, Wu M, Wang D, Zhang S, Vasquez R, Li M, Gill JG Journal of the American Academy of Dermatology 2026 Feb 94 680-683 Acral melanoma in a United States safety net hospital: retrospective cohort study Dubocq-Ortiz C, Encarnacion-Cortes V, Gill JG, Vasquez R Archives of Dermatological Research 2025 Dec 317 Conservation and divergence of metabolic phenotypes between patient tumours and matched xenografts Rao AD, Cai L, Snyman M, Walsdorf RE, Li X, Wix SN, Gard G, Brown AB, Kim J, Santos Patricio J, Muh S, Martin Sandoval M, Zacharias LG, Heimdal KA, Gu W, Homsi J, Tillman B, Sharma R, Vandergriff TW, Solmonson A, Faubert B, Mathews TP, Morrison SJ, DeBerardinis RJ, Gill JG Nature Metabolism 2025 Aug 7 1703-1713 Pathogenic mitochondrial DNA mutations inhibit melanoma metastasis Shelton SD, House S, Melo LM, Ramesh V, Chen Z, Wei T, Wang X, Llamas CB, Venigalla SS, Menezes CJ, Allies G, Krystkiewicz J, Rösler J, Meckelmann SW, Zhao P, Rambow F, Schadendorf D, Zhao Z, Gill JG, DeBerardinis RJ, Morrison SJ, Tasdogan A, Mishra P Science Advances 2024 Nov 10 Types and severity of cutaneous toxicities to BRAF inhibitors are drug-specific and discrete: A single-center cohort study Sarlashkar P, Gill JG, Heberton M Journal of the American Academy of Dermatology 2024 Nov 91 945-948 Increased presentation for vitiligo cutaneous immune related adverse events in Hispanic patients Momin ZK, Gill JG, Heberton M Archives of Dermatological Research 2024 Aug 316 The metabolism of melanin synthesis—From melanocytes to melanoma Snyman M, Walsdorf RE, Wix S, Gill JG Pigment Cell and Melanoma Research 2024 Jul 37 438-452 Understanding the Association Between Social Determinants of Health and Receipt of Immunotherapy for Melanoma Ramirez F, Vasquez R, Gill J, Riva H, Zambrano A, Samaniego M, Fernandez L, Chacon J Journal of Drugs in Dermatology 2024 May 23 311-315 Clinical Features and Outcomes of Black Patients with Melanoma Wix SN, Brown AB, Heberton M, Adamson AS, Gill JG JAMA Dermatology 2024 Mar 160 328-333 Results 1-10 of 30 1 2 3 Next Last Books Featured Books Rituximab and Future Biologic Therapies. In Comprehensive Dermatologic Drug Therapy, 3rd Edition Leonardi, CL, Heffernan, MP, and Gill, JG (2012). Saunders Publishing Company Honors & Awards Doris Duke Clinician Scientist Development Award (2023) Disease Oriented Clinical Scholar (DOCS) Award (2022) American Academy of Dermatology Presidential Citation Award (2018) Dermatology Foundation Physician-Scientist Career Development Award (2017) Dermatologist Investigator Research Fellowship (2016) UTSW Dermatology Resident Award for Leadership (2016) Dermatology Resident Award for Humanism and Professionalism (2015) Texas Health Presbyterian Hospital Intern of the Year Award (2013) Barry M. Goldwater National Scholarship (2002) University of Georgia Foundation Fellowship Scholarship (1999-2003) Professional Associations/Affiliations American Academy of Dermatology (2013) American Association for Cancer Research (2023) Society for Investigative Dermatology (2013) Society for Melanoma Research (2021)